Francisco (Frank) Castillo, Ph.D. is a Senior Consultant with BioProcess Technology Consultants with over 30 years of experience in research and process development of biologics.
From 1995 to 2007, he held positions as Chairman of the Scientific Leadership Team, Scientific Director, and Head of Fermentation and Cell Culture Development at Berlex Biosciences, a subsidiary of Schering AG. Previously, he was Director of Cell Culture and Fermentation Development at Xoma Corporation, a Visiting Scholar at U.C. Berkeley, and Founder and Head of the Fermentation Laboratory at the Venezuelan Institute of Scientific Research.
Dr. Castillo’s professional activities range from basic research in microbiology and virology to process development for the GMP production of monoclonal antibodies, recombinant proteins, vectors for gene therapy, and cells for cell-based therapies. He has been involved in the development of multiple biologics and was responsible for the CMC sections of numerous regulatory filings and has interacted with the FDA, EMEA, and other international, national, and local regulatory agencies worldwide.
Dr. Castillo holds a Ph.D. in microbiology from the College of Medicine and Dentistry of New Jersey and completed post-doctoral training at the Department of Biochemistry, University of Birmingham, U.K.